Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis

American Journal of Health-System Pharmacy

Volumn 68, Issue 16, 2011, Pages 1527-1531

  Patel, Jean A ^a   Pacheco, Susan M ^b   Postelnick, Michael ^a   Sutton, Sarah ^c  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acinetobacter baumanii; Acinetobacter infections; Aminoglycosides; Antibiotics; Antiinfective agents; Cerebral ventriculitis; Colistin; Combined therapy; Resistance; Rifampin; Tobramycin; Vancomycin

Indexed keywords

AMIKACIN; CEFTAZIDIME; COLISTIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BRAIN VENTRICULITIS; CASE REPORT; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CRANIOTOMY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FEVER; HEADACHE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOADING DRUG DOSE; LONG TERM CARE; MENTAL DISEASE; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; PRIORITY JOURNAL; REOPERATION; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80051883087     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100234     Document Type: Article

References (33)

1. Bergogne-Berezin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9:148-165 (Pubitemid 26123943)
2. Maragakis L.L., Perl T.M. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008; 46:1254-1263 (Pubitemid 351589912)
3. Rahal J.J. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006; 43(suppl 2):S95-S99 (Pubitemid 44267147)
4. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med. 2008; 358:1271-1281
5. Metan G., Alp E., Aygen B. et al. Carbapenem- resistant Acinetobacter baumannii: An emerging threat for patients with post-neurosurgical meningitis. Int J Antimicrob Agents. 2007; 29:112-113Letter. (Pubitemid 44959783)
6. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12:826-836 (Pubitemid 44151282)
7. Kasiakou S.K., Rafailidis P.I., Liaropoulos K. et al. Cure of post-traumatic recurrent multiresistant gram-negative rod meningitis with intraventricular colistin. J Infect. 2005; 50:348-352 (Pubitemid 40533374)
8. Rodriguez Guardado A., Blanco A., Asensi V. et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: Assessment of different treatments. J Antimicrob Chemother. 2008; 61:908-913 (Pubitemid 351426078)
9. Falagas M.E., Kasiakou S.K. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005; 40:1333-1341 (Pubitemid 40570245)
10. Kim B.N., Peleg A.Y., Lodise T.P. et al. Management of meningitis due to antibioticresistant Acinetobacter species. Lancet Infect Dis. 2009; 9:245-255
11. Krol V., Hamid N.S., Cunha B.A. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: Report of two cases and literature review. J Hosp Infect. 2009; 71:176-180
12. Cascio A., Conti A., Sinardi L. et al. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 2010; 14:e572-e579
13. Lopez-Alvarez B., Martin-Laez R., Farinas M.C. et al. Multidrug-resistant Acinetobacter baumannii ventriculitis: Successful treatment with intraventricular colistin. Acta Neurochir. 2009; 151:1465-1472
14. Ng J., Gosbell I.B., Kelly J.A. et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: Case series and literature review. J Antimicrob Chemother. 2006; 58:1078-1081
15. Falagas M.E., Bliziotis I.A., Tam V.H. Intraventricular or intrathecal use of polymyxins in patients with gramnegative meningitis: A systematic review of the available evidence. Int J Antimicrob Agents. 2007; 29:9-25. (Pubitemid 44959774)
16. Jain R., Danziger L.H. Multidrug-resistant Acinetobacter infections: An emerging challenge to clinicians. Ann Pharmacother. 2004; 38:1449-1459 (Pubitemid 39100202)
17. Jimenez-Mejias M.E., Pichardo-Guerrero C., Marquez-Rivas F.J. et al. Cerebrospinal fluid penetration and pharmacokinetic/ pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis. 2002; 21:212-214 (Pubitemid 34328007)
18. Ziai W.C., Lewin J.J. 3rd. Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol. 2009; 22:277-282
19. Cook A.M., Mieure K.D., Owen R.D. et al. Intracerebroventricular administration of drugs. Pharmacotherapy. 2009; 29:832-845
20. Tunkel A.R., Hartman B.J., Kaplan S.L. et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39:1267-1284 (Pubitemid 39458512)
21. Li J., Nation R.L., Owen R.J. et al. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: Promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis. 2007; 45:594-598 (Pubitemid 47328640)
22. Bassetti M., Repetto E., Righi E. et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J Antimicrob Chemother. 2008; 61:417-420
23. Giamarellos-Bourboulis E.J., Xirouchaki E., Giamarellou H. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2001; 40:117-120 (Pubitemid 32735549)
24. Haddad F.A., Van Horn K., Carbonaro C. et al. Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test. Eur J Clin Microbiol Infect Dis. 2005; 24:577-579 (Pubitemid 41414014)
25. Hogg G.M., Barr J.G., Webb C.H. Invitro activity of the combination of colistin and rifampicin against multidrugresistant strains of Acinetobacterbaumannii. J Antimicrob Chemother. 1998; 41:494-495Letter. [Erratum, J Antimicrob Chemother. 1998; 42:413.] (Pubitemid 28167511)
26. Motaouakkil S., Charra B., Hachimi A. et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect. 2006; 53:274-278 (Pubitemid 44391062)
27. Nation R.L., Li J. Optimizing use of colistin and polymyxin B in the critically ill. Semin Respir Crit Care Med. 2007; 28:604-614
28. Petrosillo N., Chinello P., Proietti M.F. et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: Clinical outcome and adverse events. Clin Microbiol Infect. 2005; 11:682-683Letter. (Pubitemid 41051389)
29. Song J.Y., Kee S.Y., Hwang I.S. et al. In vi tro act ivi ties of carbapenem/ sulbactam combination, colistin, colistin/ rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007; 60:317-322
30. Tripodi M.F., Durante-Mangoni E., Fortunato R. et al. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrugresistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Int J Antimicrob Agents. 2007; 30:537-540 (Pubitemid 350051770)
31. Yoon J., Urban C., Terzian C. et al. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2004; 48:753-757 (Pubitemid 38280320)
32. Wolff M., Joly-Guillou M.L., Farinotti R. et al. In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother. 1999; 43:1406-1411 (Pubitemid 29259334)
33. Ho Y.H., Wang L.S., Chao H.J. et al. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect. 2007; 40:537-540